» Articles » PMID: 21139145

An Update on Cryptococcus Among HIV-infected Patients

Overview
Journal Int J STD AIDS
Date 2010 Dec 9
PMID 21139145
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

Cryptococcus remains an important opportunistic infection in HIV patients despite considerable declines in prevalence during the highly active antiretroviral therapy era. This is particularly apparent in sub-Saharan Africa, where Cryptococcus continues to cause significant mortality and morbidity. This review discusses the microbiology, epidemiology, pathogenesis and clinical presentation of cryptococcal infections in HIV patients. Additionally, a detailed approach to the management of cryptococcosis is provided.

Citing Articles

Cryptococcosis-a systematic review to inform the World Health Organization Fungal Priority Pathogens List.

Dao A, Kim H, Garnham K, Kidd S, Sati H, Perfect J Med Mycol. 2024; 62(6).

PMID: 38935902 PMC: 11210623. DOI: 10.1093/mmy/myae043.


Deciphering antifungal and antibiofilm mechanisms of isobavachalcone against Cryptococcus neoformans through RNA-seq and functional analyses.

Qian W, Lu J, Gao C, Liu Q, Li Y, Zeng Q Microb Cell Fact. 2024; 23(1):107.

PMID: 38609931 PMC: 11015616. DOI: 10.1186/s12934-024-02369-2.


Mapping evidence on cryptococcal antigen infection among HIV-infected persons in sub-Saharan Africa- A scoping review protocol.

Dlamini K, Moetlhoa B, Turner A, Maluleke K, Mashamba-Thompson T PLoS One. 2023; 18(6):e0281849.

PMID: 37294775 PMC: 10256208. DOI: 10.1371/journal.pone.0281849.


Protective interaction of human phagocytic APC subsets with induces genes associated with metabolism and antigen presentation.

Nelson B, Daugherty C, Sharp R, Booth J, Patel V, Metcalf J Front Immunol. 2022; 13:1054477.

PMID: 36466930 PMC: 9709479. DOI: 10.3389/fimmu.2022.1054477.


Isolated cryptococcal osteomyelitis of the ulna in an immunocompetent patient: A case report.

Ma J, Liao L, Wan T, Yang F World J Clin Cases. 2022; 10(19):6617-6625.

PMID: 35979300 PMC: 9294900. DOI: 10.12998/wjcc.v10.i19.6617.


References
1.
Pappas P, Chetchotisakd P, Larsen R, Manosuthi W, Morris M, Anekthananon T . A phase II randomized trial of amphotericin B alone or combined with fluconazole in the treatment of HIV-associated cryptococcal meningitis. Clin Infect Dis. 2009; 48(12):1775-83. DOI: 10.1086/599112. View

2.
Graybill J, Sobel J, Saag M, van der Horst C, Powderly W, Cloud G . Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. The NIAID Mycoses Study Group and AIDS Cooperative Treatment Groups. Clin Infect Dis. 2000; 30(1):47-54. DOI: 10.1086/313603. View

3.
Lortholary O, Poizat G, Zeller V, Neuville S, Boibieux A, Alvarez M . Long-term outcome of AIDS-associated cryptococcosis in the era of combination antiretroviral therapy. AIDS. 2006; 20(17):2183-91. DOI: 10.1097/01.aids.0000252060.80704.68. View

4.
Lindberg J, Hagen F, Laursen A, Stenderup J, Boekhout T . Cryptococcus gattii risk for tourists visiting Vancouver Island, Canada. Emerg Infect Dis. 2007; 13(1):178-9. PMC: 2725802. DOI: 10.3201/eid1301.060945. View

5.
DIAMOND R, Bennett J . Prognostic factors in cryptococcal meningitis. A study in 111 cases. Ann Intern Med. 1974; 80(2):176-81. DOI: 10.7326/0003-4819-80-2-176. View